Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:59 PM EDT
118.28quote price arrow up+0.03 (+0.03%)
Volume
124,190
Close
118.25quote price arrow up+0.18 (+0.15%)
Volume
3,705,401
52 week range
115.03 - 390.60
Loading...
  • Open118.44
  • Day High122.58
  • Day Low118.08
  • Prev Close118.07
  • 52 Week High390.60
  • 52 Week High Date09/30/21
  • 52 Week Low115.03
  • 52 Week Low Date09/29/22

Key Stats

  • Market Cap46.259B
  • Shares Out391.20M
  • 10 Day Average Volume5.55M
  • Dividend-
  • Dividend Yield-
  • Beta1.71
  • YTD % Change-53.44

KEY STATS

  • Open118.44
  • Day High122.58
  • Day Low118.08
  • Prev Close118.07
  • 52 Week High390.60
  • 52 Week High Date09/30/21
  • 52 Week Low115.03
  • 52 Week Low Date09/29/22
  • Market Cap46.259B
  • Shares Out391.20M
  • 10 Day Average Volume5.55M
  • Dividend-
  • Dividend Yield-
  • Beta1.71
  • YTD % Change-53.44

RATIOS/PROFITABILITY

  • EPS (TTM)32.80
  • P/E (TTM)3.60
  • Fwd P/E (NTM)7.65
  • EBITDA (TTM)15.945B
  • ROE (TTM)113.86%
  • Revenue (TTM)22.995B
  • Gross Margin (TTM)82.29%
  • Net Margin (TTM)61.12%
  • Debt To Equity (MRQ)4.24%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

Pro Picks: Watch all of Friday's big stock calls on CNBC
VIDEO8:2708:27
Pro Picks: Watch all of Friday's big stock calls on CNBC

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases...
Noubar Afeyan Ph.D.
Non-Executive Independent Chairman of the Board, Co-Founder
Stephane Bancel
Chief Executive Officer, Director
Stephen Hoge M.D.
President
James Mock
Chief Financial Officer
Juan Andres
Chief Technical Operations and Quality Officer
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
134.88+1.28+0.96%
REGN
Regeneron Pharmaceuticals Inc
688.87-2.95-0.43%
BIIB
Biogen Inc
267.00+2.72+1.03%
ILMN
Illumina Inc
190.79-3.02-1.56%
ALNY
Alnylam Pharmaceuticals Inc
200.16-9.23-4.41%